Apollo Hospitals Enterprise Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 200% at ₹10/Share	14-Aug-2026	14-Aug-2026
DividendsInterim Dividend of 200% at ₹10/Share	16-Feb-2026	16-Feb-2026
DividendsFinal Dividend of 200% at ₹10/Share	19-Aug-2025	19-Aug-2025
DividendsInterim Dividend of 180% at ₹9/Share	14-Feb-2025	15-Feb-2025

Mutual Fund Holder	Jul 26 Shares held	Aug 26 Shares held
UTI Nifty 50 ETF	6.75 Lac	6.84 Lac (1.4%)
UTI Nifty 50 Index Fund - Regular Plan - IDCW	2.72 Lac	2.75 Lac (1.15%)
UTI Healthcare Fund - Regular Plan - IDCW	53.00 k	53.00 k no change
UTI Arbitrage Fund - Regular Plan - Growth	35.38 k	36.88 k (4.24%)
UTI Multi Asset Allocation Fund - Regular Plan - Growth	23.09 k	19.39 k (16.02%)

Vimal K

8 Sep • 8:58 AM · SEBI-Registered Analyst

Nifty Outlook for 08-Sep-2026 Looks Bearish

The overall trend of Nifty looks bearish, and the sellers are in control over the markets. Sell on rise would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains above the resistance level. Can Initiate buying only if prices continue to sustain above the resistance level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 23900 Resistance 2 - 23940 Support 1 - 23695 Support 2 - 23670 Happy Learning, Happy Trading and have a wonderful day. Top Gainers : APOLLOHOSP, LT, COALINDIA. Top Losers : INFY, HDFCLIFE, SBILIFE.

APOLLOHOSP

VIJAY KUMAR GUPTA

7 Sep • 2:42 PM · SEBI-Registered Analyst

Apollo Hospitals Q1 FY27: Revenue Up 21%, All Three Segments

APOLLOHOSP

Apollo Hospitals Enterprise Limited reported Q1 FY27 results for the June 2026 quarter on 12 August. Q1 FY27 numbers (consolidated): Revenue: Rs 7,044 crore, up 21% YoY from Rs 5,842 crore EBITDA: Rs 1,092 crore, up 28% YoY; margin 15.5% vs 14.6% PAT: Rs 581 crore, up 34% YoY; EPS Rs 40.36 Healthcare Services: revenue Rs 3,567 crore, up 22%; EBITDA margin 24%; ROCE 28.5% Apollo HealthCo: revenue Rs 2,977 crore, up 20%; EBITDA margin 5.8% vs 3.8% Apollo 24/7 digital loss narrowed to Rs 10 crore; breakeven targeted Q3 FY27 Management guides 18 to 20% FY27 hospital revenue growth. Gurugram commissions Q3 FY27. Apollo plans 5,800 beds over five years at Rs 11,150 crore capex. Final dividend Rs 10, ex 14 August. HealthCo demerger is a pending catalyst. Apollo Hospitals [

APOLLOHOSP

][***** shares trade at Rs 8,655.06 (7 Sep 2026, 11:14 AM IST), up 15 percent in a year, 4 percent under the Rs 9,056 high. P/E 59.6; sector average near 42. My view: the integrated model is delivering simultaneously across hospitals, pharmacy and digital, all three growing margins together for the first time. At 59x, well above the sector, the market is paying for the HealthCo demerger optionality and the 5,800-bed cycle. That is a reasonable bet if Gurugram launch costs stay contained and the digital breakeven prints in Q3. Not a compelling entry at 4 percent from the 52-week high; hold, add only on a pullback or a Q3 digital breakeven. Levels: Rs 8,555 to 8,585, this week's base, is support; Rs 8,713 the first reclaim; Rs 9,056 the high. Disclosure: Vijay Kumar Gupta, SEBI Registered Research Analyst, INH000020226, Vijay Gupta Advisory. SEBI registration and NISM certification do not guarantee performance or assure returns. Securities markets are subject to market risks. No holdings in the subject company.

Dhwani Patel

3 Sep • 9:32 PM · SEBI-Registered Analyst

Apollo Hospital - Thematic Play in Hospitals Space

APOLLOHOSP

Enterprise remains one of the strongest structural growth stories in India’s organised healthcare sector, and the latest operating numbers continue to support the premium valuation that the market has assigned to the company. FY26 was a strong year: consolidated revenue crossed ₹25,000 crore for the first time, reaching about ₹25,229 crore, up 16% YoY, while EBITDA increased 25% to ₹3,769 crore and PAT rose 34% to ₹1,942 crore. More importantly, this was not simply a low-base profit recovery; the underlying hospital business is benefiting from increasing patient volumes, higher complexity of procedures and improving utilisation of the existing network. The company is also positioning itself for a substantial capacity-led growth cycle. Apollo has approximately 10,000 beds today and has announced plans to add more than 5,800 beds over the next five years. Earlier expansion plans targeted around 13,000 beds by FY30, with a significant proportion of the incremental capacity focused on complex care. This is strategically important because cardiology, oncology, neurology, gastroenterology, orthopaedics and transplant procedures generally command higher revenue intensity than basic healthcare services. In Q3FY26, for example, Apollo reported 22.6% growth in complex-care revenue, while organ-transplant revenue grew about 40%, illustrating where the higher-value growth is coming from.

Pradeep Carpenter

28 Aug • 2:44 PM · SEBI-Registered Analyst

Apollo Hospitals Eyes Breakout Above Key Resistance

APOLLOHOSP

is showing a positive technical setup after recovering from its recent correction and moving back above the short-term moving averages. The stock is currently testing a descending trendline resistance, making the ₹8,900–₹9,000 zone crucial for the next directional move. Technical View CMP: ₹8,881 | Time Frame: Daily The stock is trading above the 10-EMA (₹8,803), 20-EMA (₹8,807), 50-EMA (₹8,716) and 100-DMA (₹8,402), indicating that the broader trend remains positive. RSI is around 54, suggesting balanced-to-positive momentum with sufficient room for further upside. MACD is showing signs of improvement, with the MACD line moving above the signal line, supporting a potential recovery in momentum. Key Levels Immediate Resistance: ₹8,900–₹9,000 Next Targets: ₹9,050 / ₹9,150 / ₹9,250 Immediate Support: ₹8,800 Major Support: ₹8,700–₹8,715 Strong Support: ₹8,400 Outlook A decisive daily close above ₹9,000, preferably supported by strong volumes, could confirm a breakout from the descending trendline and trigger further upside towards ₹9,050 and ₹9,150, with ₹9,250 as the next major target. On the downside, ₹8,800 is the immediate support zone. Holding above ₹8,700–₹8,715 would keep the short-term structure constructive. A sustained close below ₹8,700 could weaken the setup and lead to further consolidation. Overall View: Moderately Bullish — A sustained breakout above ₹9,000 could strengthen the upside momentum. This is a technical analysis based on chart structure and indicators, not a recommendation to buy or sell.

Vimal K

25 Aug • 7:57 PM · SEBI-Registered Analyst

Nifty Outlook for 26-Aug-2026 Looks Range Bound

The overall trend of Nifty looks to be in a range, and thus the markets might move either side. Buy on dips and sell on rise would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains below the support level or above the resistance level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 24410 Resistance 2 - 24455 Support 1 - 24295 Support 2 - 24270 Happy Learning, Happy Trading and have a wonderful day Top Gainers : ADANIENT, MAXHEALTH, APOLLOHOSP. Top Losers : HDFCLIFE, CIPLA, ONGC.

ADANIENT

Manjushri Sharma SEBI RA

20 Aug • 11:25 PM · SEBI-Registered Analyst

Apollo Hospitals: Promoter Pledge Revoke Worth ₹100.63 Crore Reported

APOLLOHOSP

According to the transaction data shown, 115,000 shares were involved in the pledge-revoke transaction at an average price of approximately ₹8,750.43 per share, representing a transaction value of around ₹100.63 crore. The reported holding percentage remained at approximately 1.10% before and after the transaction, indicating no material change in the overall reported ownership percentage. What Does Pledge Revoke Mean? A pledge is generally created when shares are offered as collateral against financing or other obligations. A pledge revoke/release indicates that previously pledged shares have been released from the pledge arrangement. Importantly, a pledge revoke is different from an open-market purchase or sale. Therefore, the transaction should primarily be understood as a change in the encumbrance status of the shares rather than automatically interpreting it as buying or selling activity. Key Transaction Details Particular Details Company Apollo Hospitals Enterprise Ltd. Transaction Type Pledge Revoke Shares Involved 115,000 Average Price ₹8,750.43 Approx. Value ₹100.63 Crore Reported Holding ~1.10% → ~1.10% Broadcast Date 20 August 2026 Apollo Hospitals maintains an investor-relations section containing regulatory filings and disclosures, including information relating to its listed securities and corporate governance framework. Why This Disclosure Is Relevant Insider and promoter disclosures are useful for understanding changes in share ownership, pledging and encumbrance status. However, each transaction needs to be interpreted according to its specific nature. In this case, the key information is the release of the pledge on 115,000 shares, rather than an equity purchase or sale. This article is strictly for educational and informational purposes and does not constitute investment advice, a recommendation, or a trading call.

Apollo Hospitals Enterprise Ltd Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Apollo Hospitals Enterprise Ltd 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Apollo Hospitals Enterprise Ltd?

What is the market cap of Apollo Hospitals Enterprise Ltd?

Should I buy Apollo Hospitals Enterprise Ltd stock now?

What is the 52 week high and low of Apollo Hospitals Enterprise Ltd?

Is the Apollo Hospitals Enterprise Ltd stock good to buy?

Is Apollo Hospitals Enterprise Ltd a good buy for the long term?

Is Apollo Hospitals Enterprise Ltd overvalued or undervalued?

What is the PE and PB ratio of Apollo Hospitals Enterprise Ltd?